Moderna targets $1.1B in R&D spending cuts, drops 5 programs …

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Sep 12, 2024  · Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The decision to shrink the budget by more than 20% follows commercial setbacks that have persuaded the …

fiercebiotech.com

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Dec 19, 2024  · Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The decision to shrink the budget by more than 20% follows commercial setbacks that have persuaded the …

biotech-insider.com

Moderna To Cut R&D Spending $1.1 B - STAT

2 weeks from now

Sep 12, 2024  · Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who …

statnews.com

Moderna To Cut R&D Expenses By $1.1B | Pharma Manufacturing

2 weeks from now

Sep 12, 2024  · To streamline operations, Moderna said it will cut R&D expenses by $1.1 billion, focusing on commercializing late-stage products while maintaining profitability through 2027. …

pharmamanufacturing.com

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

Jan 27, 2025  · Moderna said the changes will reduce the cumulative spend on R&D between 2025 and 2028 to $16 billion from $20 billion, and allow it to break even financially in 2028.

pharmaphorum.com

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs, Launch …

2 weeks from now

Sep 12, 2024  · Moderna said it plans to "break even" on an operating cash cost basis with $6 billion in revenue in 2028. The company previously said it expects to break even and return to …

nbcsandiego.com

Moderna Cuts Five Programmes To Save $1.1bn In R&D Costs

2 weeks from now

Sep 12, 2024  · Moderna will cut five clinical programmes amid plans to reduce $1.1bn of R&D costs following years of declining revenues.. The company highlighted its rejig in priorities at …

pharmaceutical-technology.com

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - MSN

2 weeks from now

Moderna projects fiscal 2025 revenue of between $2.5 billion to $3.5 billion compared to analyst projections of $2.9 billion, and said Thursday that it expects to break even on an operating …

msn.com

Moderna To Slash Costs By $1.1B - LinkedIn

2 weeks from now

Sep 12, 2024  · Moderna plans to cut costs by $1.1 billion by 2027 as the biotech company realigns its business amid waning demand for its COVID-19 vaccine. ... Moderna plans $1.1B …

linkedin.com

Moderna Plans $1.1B In R&D And Program Cuts, Delays Break-even …

2 weeks from now

Sep 12, 2024  · Mod­er­na plans $1.1B in R&D and pro­gram cuts, de­lays break-even point to 2028

endpts.com

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024  · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

StockWatch: Moderna's $1.1B R&D Cut, Profitability Delay Jolt …

2 weeks from now

Sep 16, 2024  · The mRNA vaccine pioneer revealed that it had pushed back by two years, from 2026 to 2028, its plans to break even on an operating cash cost basis—which excludes stock …

genengnews.com

Moderna Falls On R&D Cuts, Filing Delays, Terminated Programs

2 weeks from now

Sep 12, 2024  · Moderna Inc.’s shares (NASDAQ:MRNA) sank 19% to a $64.11 low in early trading Sept. 12 as investors learned during the annual R&D Day event of a $1.1 billion …

bioworld.com

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024  · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com